Global health solidarity in the HIV and hypertension disease response.
作者信息
Ngeno G Titus K, Bloomfield Gerald S
机构信息
Duke Global Health Institute and Department of Medicine.
Duke Clinical Research Institute, Duke University, Durham, NC, USA.
出版信息
AIDS. 2025 Mar 1;39(3):319-320. doi: 10.1097/QAD.0000000000004083. Epub 2025 Jan 30.
Abstract
摘要
相似文献
1
Global health solidarity in the HIV and hypertension disease response.全球卫生在应对艾滋病毒和高血压疾病方面的团结。
AIDS. 2025 Mar 1;39(3):319-320. doi: 10.1097/QAD.0000000000004083. Epub 2025 Jan 30.
2
Global health inequalities and the need for solidarity: a view from the Global South.全球卫生不平等与团结的必要性：来自全球南方的观点。
Dev World Bioeth. 2018 Sep;18(3):241-249. doi: 10.1111/dewb.12182. Epub 2017 Dec 20.
3
Solidarity and its decoloniality in global health ethics.全球卫生伦理中的团结及其去殖民化
Int J Equity Health. 2025 Jan 16;24(1):13. doi: 10.1186/s12939-025-02380-y.
4
Rethinking solidarity towards equity in global health: African views.重新思考全球卫生公平中的团结：非洲观点。
Int J Equity Health. 2023 Mar 24;22(1):52. doi: 10.1186/s12939-023-01830-9.
5
Global solidarity, migration and global health inequity.全球团结、移民与全球健康不平等。
Bioethics. 2012 Sep;26(7):382-90. doi: 10.1111/j.1467-8519.2012.01991.x.
6
Building solidarity during COVID-19 and HIV/AIDS.在新冠疫情和艾滋病中建立团结。
Bioethics. 2024 Feb;38(2):121-128. doi: 10.1111/bioe.13247. Epub 2023 Dec 6.
7
Solidarity and HIV Testing Willingness During the COVID-19 Epidemic: A Study Among Men Who Have Sex With Men in China.新冠疫情期间的团结与 HIV 检测意愿：一项针对中国男男性行为者的研究。
Front Public Health. 2021 Dec 9;9:752965. doi: 10.3389/fpubh.2021.752965. eCollection 2021.
8
Solidarity and Community Engagement in Global Health Research.全球健康研究中的团结与社区参与。
Am J Bioeth. 2020 Jun;20(5):43-56. doi: 10.1080/15265161.2020.1745930.
9
Solidarity: a (new) ethic for global health policy.团结：全球卫生政策的一种（新）伦理准则。
Health Care Anal. 2006 Dec;14(4):215-36. doi: 10.1007/s10728-006-0030-8.
10
Social Inequality and Solidarity in Times of COVID-19.社会不平等与新冠疫情时期的团结
Int J Environ Res Public Health. 2021 Jun 11;18(12):6339. doi: 10.3390/ijerph18126339.
本文引用的文献
1
Incidence of high blood pressure among Kenyan adults with HIV.肯尼亚成年艾滋病毒感染者中的高血压发病率。
AIDS. 2025 Mar 1;39(3):281-289. doi: 10.1097/QAD.0000000000004050. Epub 2024 Oct 29.
2
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.在接受整合酶抑制剂、替诺福韦艾拉酚胺或两者联合治疗的人群中，体重指数变化与高血压和血脂异常风险的相关性与其他当代抗逆转录病毒治疗方案相比：来自 RESPOND 联盟队列的多中心前瞻性观察研究。
Lancet HIV. 2024 May;11(5):e321-e332. doi: 10.1016/S2352-3018(23)00328-4. Epub 2024 Apr 12.
3
Sustaining the HIV/AIDS response: PEPFAR's vision.维持对艾滋病毒/艾滋病的应对：总统艾滋病紧急救援计划的愿景。
J Int AIDS Soc. 2023 Dec;26(12):e26192. doi: 10.1002/jia2.26192.
4
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.匹伐他汀预防 HIV 感染患者的心血管疾病。
N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23.
5
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.从增强型蛋白酶抑制剂转换为多替拉韦的心血管疾病高危人类免疫缺陷病毒感染者的高血压发病率和血压变化：96周随机NEAT-022试验的事后分析
Clin Infect Dis. 2023 Oct 5;77(7):991-1009. doi: 10.1093/cid/ciad297.
6
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.心血管风险和艾滋病毒（HIV）感染者的健康状况（适合初级预防）：来自 REPRIEVE 试验的见解。
Clin Infect Dis. 2021 Dec 6;73(11):2009-2022. doi: 10.1093/cid/ciab552.
7
Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.HIV 感染成人中的高血压：新的病理生理机制
Hypertension. 2018 Jul;72(1):44-55. doi: 10.1161/HYPERTENSIONAHA.118.10893. Epub 2018 May 18.
8
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.在START（抗逆转录病毒治疗的战略时机）试验中，HIV阳性参与者立即与延迟启动抗逆转录病毒治疗时心血管疾病风险因素的变化。
J Am Heart Assoc. 2017 May 22;6(5):e004987. doi: 10.1161/JAHA.116.004987.
9
Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya.在肯尼亚西部，高血压和肥胖症是 HIV 血清阳性患者的心血管风险因素。
PLoS One. 2011;6(7):e22288. doi: 10.1371/journal.pone.0022288. Epub 2011 Jul 14.
10
Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases.为何要重新发明轮子？利用 HIV 扩大规模的经验教训来应对非传染性疾病。
Glob Public Health. 2011;6(3):247-56. doi: 10.1080/17441692.2011.552068.
Zotero 插件